8-K: Nuvve Holding Corp. Secures $250,000 in Convertible Note Financing
Private Placement Announcement
Nuvve Holding Corp. has entered into a securities purchase agreement for a $250,000 convertible note and warrant offering to an institutional investor.
Summary
- Nuvve Holding Corp. has secured a $250,000 senior convertible promissory note from an accredited institutional investor.
- The note has a 10% original issue discount, resulting in net proceeds of $225,000 for the company.
- The note is convertible into common stock at a price of $2.931 per share, which is a 10% discount to the closing price prior to the agreement.
- The investor also received a warrant to purchase common stock equal to 100% of the shares the note is convertible into, at an exercise price of $3.257 per share.
- The note matures in 12 months, with an option for the company to extend it by six months under certain conditions.
- The note accrues interest at 8% per annum, increasing to 18% upon an event of default.
- Principal and interest payments are due in equal monthly installments starting February 1, 2025, and can be paid in cash or common stock at the company's option.
- The investor has an option to purchase up to an additional $1,000,000 in notes and warrants after six months, with a conversion and exercise price at 95% of the average of the five lowest trading prices in the ten trading days prior to the exercise of the option.
- The company intends to use the net proceeds for working capital and general corporate purposes.
Sentiment
Score: 4
Explanation: The financing provides needed capital, but the terms are not particularly favorable for the company, with a discount, high interest rate, and full ratchet anti-dilution protection. The potential for dilution is also a concern.
Positives
- The financing provides Nuvve with immediate capital for working capital and general corporate purposes.
- The convertible note structure allows for potential future equity conversion, which could be beneficial for the company's capital structure.
- The additional investment option provides the company with a potential source of further funding in the future.
- The company has the option to pay monthly installments with shares of common stock, which could help conserve cash.
Negatives
- The 10% original issue discount reduces the net proceeds received by the company.
- The 8% interest rate, which increases to 18% upon default, could be a significant expense for the company.
- The full ratchet anti-dilution protection on the conversion price could lead to significant dilution for existing shareholders if the stock price declines.
- The investor's ability to convert the note at a discount to the market price could put downward pressure on the stock price.
- The potential for a large number of shares to be issued upon conversion and exercise of warrants could dilute existing shareholders.
Risks
- The company's ability to repay the note and interest is dependent on its future financial performance.
- The conversion of the note and exercise of the warrants could significantly dilute existing shareholders.
- The full ratchet anti-dilution protection could lead to a lower conversion price and further dilution if the stock price declines.
- The investor's ability to convert the note at a discount to the market price could put downward pressure on the stock price.
- The company may need to seek stockholder approval to issue more than 19.99% of its outstanding common stock.
Future Outlook
The company intends to use the net proceeds from the private placement for working capital and general corporate purposes. The investor has an option to purchase up to an additional $1,000,000 in notes and warrants after six months.
Management Comments
- The document does not contain any direct quotes from management, but it does state that the company intends to use the net proceeds from the private placement for working capital and general corporate purposes.
Industry Context
This type of financing is common for companies seeking to raise capital, particularly smaller companies or those in the growth phase. The use of convertible notes and warrants is a way to attract investors while providing flexibility for the company.
Comparison to Industry Standards
- The terms of the convertible note, including the discount, interest rate, and conversion price, are within the range of what is typically seen in similar private placements.
- The full ratchet anti-dilution protection is a relatively aggressive term that is more favorable to the investor and less favorable to the company and its existing shareholders.
- The additional investment option is a common feature in these types of financings, providing the investor with the potential for further participation in the company's growth.
- The 19.99% exchange cap is a standard provision to avoid the need for shareholder approval for the issuance of shares.
Related Party Transactions
- The company entered into a stock repurchase agreement with Gregory Poilasne, its CEO, to buy back 1,680 shares of common stock for $0.168.
Stakeholder Impact
- Shareholders may experience dilution due to the conversion of the note and exercise of the warrants.
- Creditors may be impacted by the senior ranking of the note.
- Employees may benefit from the company's improved financial position.
Next Steps
- The company will file a registration statement for the resale of the shares issued under the note and warrant.
- The company will begin making monthly amortization payments on the note starting February 1, 2025.
- The company may seek stockholder approval to issue more than 19.99% of its outstanding common stock.
- The investor may exercise its option to purchase additional notes and warrants after six months.
Key Dates
| Date | Description |
|---|---|
| December 31, 2024 | Date of the securities purchase agreement, issuance of the convertible note and warrant, and stock repurchase agreement with CEO. |
| February 1, 2025 | Commencement of monthly amortization payments on the convertible note. |
| January 7, 2025 | Date of the 8-K filing. |
| December 31, 2025 | Maturity date of the convertible note. |
| June 30, 2026 | Potential extended maturity date of the convertible note. |
| December 31, 2029 | Expiration date of the warrant. |
Keywords
convertible note, warrant, financing, securities purchase agreement, institutional investor, common stock, dilution, working capital, capital raise, antidilution
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.